baber/WOPTO huggingface dataset:
Patent NZ-237644-A (NZ)
Title: Substituted azole derivatives, preparation and pharmaceutical compositions thereof
Inventor: WAGNER ADALBERT
IPC: A61K31/44
Filed: 1991-03-28
Abstract: The invention relates to compounds of the formula <IMAGE> in which X, Y and Z are identical or different and are N or CR<2>, R<1> and R<2> are as defined in the description, L is an alkylene radical, q = 0 or 1, and A is the radical of a fused heterobicycle. The invention furthermore relates to a method for the preparation of the abovementioned compounds, to compositions containing them, and to their use.
Patent NZ-239023-A (NZ)
Title: N-substituted-hydroxyalkyl piperidine derivatives and pharmaceutical
Inventor: BARNEY CHARLOTTE LOUISE
IPC: A61K31/4465
Filed: 1991-07-18
Abstract: The present invention relates to a group of compounds which are novel substituted piperidines and which act to inhibit the synthesis of cholesterol in mammals and in fungi.
Patent NZ-241455-A (NZ)
Title: Rubidium and caesium salts of diclofenac and pharmaceutical compositions thereof
Inventor: GRAFE INGOMAR
IPC: C07C229/42
Filed: 1992-01-30
Abstract: Novel salts of 2-(2,6-dichloroanilino)phenylacetic acid of the general formula (I) 
<IMAGE>
 in which Me represents a rubidium or caesium atom, and also a process for the preparation of these salts and pharmaceutical preparations containing these salts are described. The novel salts or the pharmaceutical preparations containing the salts can be employed successfully for the treatment of inflammatory and rheumatic processes and pain conditions.
Patent NZ-244476-A (NZ)
Title: Lead free adherent roof flashing with stress damping and foil layers
Inventor: LARSEN NIELS ADELHOLM
IPC: E04D3/35
Filed: 1992-09-24
Abstract: A lead-free plate-shaped roof flashing material comprises a sandwich structure in which a stress damping and stabilizing layer of ductile material is completely covered on one side and at least partly covered on the other side by preferably metallic foil sheetings, e.g. of aluminum foil, designed with densely positioned flattened folded sections having such a form, e.g. closed inverted pleats, that a material layer of each folded section gets into contact with the stress damping and stabilizing layer only when the folded sections open in connection with deforming the flashing material to make it fit to the roofing.
Patent NZ-258697-A (NZ)
Title: Elk-l polypeptide, coding sequence and vector therefor
Inventor: LYMAN STEWART DAVID
IPC: C07K16/24
Filed: 1993-11-15
Abstract: Antibodies to elk ligand (elk-L) polypeptides as well as DNA sequences, vectors and transformed host cells useful in providing elk-L polypeptides. The elk-L polypeptide binds to a cell surface receptor that is a member of the tyrosine kinase receptor family.
Patent NZ-271314-A (NZ)
Title: Child proof dispenser has a bottle with a reciprocating dispenser and an irremovable cap with lower aligned central openings
Inventor: PUTTEMAN PETER
IPC: G01F11/02
Filed: 1994-06-30
Abstract: PCT No. PCT/EP94/02149 Sec. 371 Date Dec. 12, 1995 Sec. 102(e) Date Dec. 12, 1995 PCT Filed Jun. 30, 1994 PCT Pub. No. WO95/01924 PCT Pub. Date Jan. 19, 1995A childproof device (1) for holding and dispensing liquids, in particular medicines, that provides precise dosages of liquid, comprising a bottle (2), a cap (5) which is irremovable from the bottleneck (4), said cap being associated with a hollow cylinder (6) extending axially to near the bottle bottom (3) and a reciprocating dispenser comprising a barrel (8) and a plunger (9). The dispenser provides the only means of getting medicine out of the bottle since the cylinder associated with the cap prevents the contents of the bottle from being poured or shaken out. The device is easily assembled and can be stored, sold and used as supplied by the manufacturer.
Patent NZ-277403-A (NZ)
Title: Plant derived dilapidated extract compositions that inhibit apoptosis
Inventor: BATHURST IAN CYRIL
IPC: C12N5/08
Filed: 1994-11-30
Abstract: The present invention is to methods of obtaining plant-derived compositions that inhibit apoptosis, the compositions obtained thereby, compositions comprising the composition, and methods of use thereof.
Patent NZ-294488-A (NZ)
Title: Cell disease diagnosis by laster induced differential normalised fluorescence spectra
Inventor: VO-DINH TUAN
IPC: A61B5/00
Filed: 1995-09-29
Abstract: An apparatus and method for cancer diagnosis are disclosed. The diagnostic method includes the steps of irradiating a tissue sample with monochromatic excitation light, producing a laser-induced fluorescence spectrum from emission radiation generated by interaction of the excitation light with the tissue sample, and dividing the intensity at each wavelength of the laser-induced fluorescence spectrum by the integrated area under the laser-induced fluorescence spectrum to produce a normalized spectrum. A mathematical difference between the normalized spectrum and an average value of a reference set of normalized spectra which correspond to normal tissues is calculated, which provides for amplifying small changes in weak signals from malignant tissues for improved analysis. The calculated differential normalized spectrum is correlated to a specific condition of a tissue sample.
Patent NZ-312136-A (NZ)
Title: Layered tablet for the controlled release of active substances
Inventor: CREMER KARSTEN
IPC: A61K9/22
Filed: 1996-06-24
Abstract: PCT No. PCT/EP96/02736 Sec. 371 Date Jan. 7, 1998 Sec. 102(e) Date Jan. 7, 1998 PCT Filed Jun. 24, 1996 PCT Pub. No. WO97/02812 PCT Pub. Date Jan. 30, 1997A layered tablet for the controlled release of active substances in a liquid medium comprising at least one active substance-containing, layered matrix with contact surfaces to the liquid medium which are at least partially provided with a cover layer delaying or preventing the active substance release, is characterized by the fact that the cover layer is at least one additional layer lying with thickness gradients on contact surfaces of the layered, prefabricated matrix, or that the matrix is at least one additional layer lying with thickness gradients on contact surfaces of the layered, prefabricated cover layer, which additional layer is applied by pressing powdery or granular material on the layered, prefabricated matrix or on the layered, prefabricated cover layer.
Patent NZ-324974-A (NZ)
Title: A composition comprising n-alkyl thiophosphoric triamide and solvent and method for producing a fertiliser comprising this
Inventor: OMILINSKY BARRY A
IPC: C05G3/90
Filed: 1996-12-10
Abstract: Improved solvent systems for the formulation of N-alkyl thiophosphoric triamide urease inhibitors. These formulations enable the preparation of stable concentrated solutions of N-alkyl thiophosphoric triamides for storage, transportation, and eventual impregnation onto solid urea containing fertilizers and incorporation into liquid urea containing fertilizer compositions. These formulations are comprised primarily of a solvent selected from the group consisting of glycols and glycol derivatives. Optionally, in addition to the glycol base solvent, the formulations can contain a co-solvent selected from the group consisting of liquid amides, 2-pyrrolidone and N-alkyl 2-pyrrolidones, and/or a nonionic surfactant selected from the group consisting of alkylaryl polyether alcohols. The presence of the co-solvent and/or surfactant has been found to impart desirable properties to the formulations under certain conditions. N-alkyl thiophosphoric triamides have been known for some time to be effective inhibitors of the activity of urease enzymes, however, commercial use has been inhibited by the lack of an acceptable carrier. They are often thermally and hydrolytically unstable and difficult to handle. The use of the solvent systems offers many advantages including: (1) improved stability of the active ingredient urease inhibitor; (2) excellent solubility characteristics; (3) extremely low flammability and toxicity of the solvents; (4) excellent cold temperature storage and handling characteristics with the addition of the liquid amide co-solvent; and (5) good adsorption characteristics onto solid urea containing fertilizers and excellent miscibility with liquid urea containing fertilizer formulations.
Patent NZ-332471-A (NZ)
Title: Dual-mode satellite/terrestrial mobile communication unit
Inventor: KIUCHI KAZUYA
IPC: H04M1/725
Filed: 1998-02-25
Abstract: A base unit A with an antenna 5A for communication with satellites can be mechanically and electrically coupled to a mobile terrestrial unit B such as a mobile telephone handset.  The terrestrial unit provides the human interface keys, display, microphone and loudspeaker, and perhaps also the radio processing function for the satellite unit when the units are coupled together.  The unit B may perform as a translator between the satellite unit and a remote transceiver.
Patent NZ-336436-A (NZ)
Title: Solid dosage forms and method for ameliorating male erectile dysfunction
Inventor: JOHNSON EDWARD STEWART
IPC: A61K31/473
Filed: 1998-01-16
Abstract: This use of a pharmaceutical composition is for treatment of male erectile dysfunction.  The composition is for oral administration and comprises a carrier and active ingredient selected from a dopamine agonist, testosterone and mixtures thereof, in the form of a fast-dispersing dosage form designed to release the active ingredient rapidly in the oral cavity.
Patent NZ-501570-A (NZ)
Title: Benzo(5,6) cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
Inventor: NJOROGE F GEORGE
IPC: A61K31/513
Filed: 1998-06-15
Abstract: A compound represented by the structural formula I or an N-oxide thereof, or a pharmaceutically acceptable salt or solvate thereof, wherein, R and R2 are independently selected from halo, R1 and R3 are independently selected from the group consisting of H and halo, provided that at least one of R1 and R3 is H, W is N, CH or C when the double bond is present at the C-11 position, R4 is -(CH2)nR5 or the compound represented by structural formula II, R5 is A, B or C, R6 is R5 or D, Z1 and Z2 are independently selected from the group consisting of =O and =S, n is 1-6 and n1 is 0 or 1. These compounds are useful for treating tumour cells that express an activated ras oncogene and also for inhibiting farnesyl protein transferase.
Patent NZ-503718-A (NZ)
Title: Apolipoprotein A-I (ApoA-I) agonists and their use to treat dyslipidemic disorders and prevent toxic shock
Inventor: DASSEUX JEAN-LOUIS
IPC: A61K38/17
Filed: 1998-09-28
Abstract: Peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I are described.  The peptides and peptide analogues are useful to treat a variety of disorders associated with dyslipidemia and toxic shock.
Patent NZ-508338-A (NZ)
Title: Process for removing coating from vitreous surface using ammonium bifluoride
Inventor: BOURNE ARTHUR
IPC: C03C17/00
Filed: 1999-06-02
Abstract: A method for creating a decorative coating on vitreous surfaces, notably on bottles is disclosed. The process involves the removal of any existing slip coating using an ammonium bifluoride solution, rinsing and drying the objects concerned. The coating is a polyurethane coating applied as a vapour curable liquid pre-polymer. The resultant coating exhibits improved adhesion and resistance to scratching and decorative finishes can be incorporated into the coating.
Patent NZ-517211-A (NZ)
Title: An immunogenic composition comprising a heat shock protein (hsp) coupled to a heterologous antigenic polypeptide
Inventor: SHANNON ANTHONY DOUGLAS
IPC: A61K47/42
Filed: 2000-08-18
Abstract: A method is provided of producing an immunogenic complex comprising a heat shock protein (HSP) coupled to a heterologous antigenic polypeptide.  The method comprises: (a) expressing the antigenic polypeptide in a cell that bas has been subjected to a stimulus which causes the induction of a heat shock response in the cells; and (b) recovering the antigenic polypeptide coupled to one or more HSPS from the cell or culture medium. Also provided are immunogenic compositions comprising a heat shock protein derived from a non-mammalian eukaryote coupled to a heterologous antigenic polypeptide which composition is capable of inducing an immune response to the antigenic polypeptide in a human or animal.
Patent NZ-517252-A (NZ)
Title: Replaceable inking arrangement in a can decorator
Inventor: WILLIAMS ROBERT
IPC: B41F17/22
Filed: 2000-07-19
Abstract: In a can decorator 10, substituting one inking arrangement 30 by another inking arrangement 32 to facilitate reconfiguration of each inking arrangement with minimal down time while the other inking arrangement is inking cans being decorated. First and second inking arrangements are supported on and spaced 90 or 180 apart around a rotation axis of a plate 60, which is rotatable to bring each of the inking arrangements to a position radially inward of the can handling apparatus of the can decorator. Each inking arrangement is shiftable laterally inward on the plate away from the can handling apparatus when the plate is to be rotated and laterally shifted outwardly toward the can handling apparatus after the plate has been rotated and the new inking arrangement is positioned laterally inward of the can handling apparatus. In one alternate embodiment, the inking arrangements are on a plate that is reciprocated laterally to bring each inking arrangement in turn to the can handling apparatus. In another alternate embodiment, the inking arrangements are on respective tracks on a Y-shape arrangement to bring each inking arrangement in turn to the can handling apparatus
Patent NZ-522214-A (NZ)
Title: Method and system for treating a hydrocarbon containing formation
Inventor: BERCHENKO ILYA EMIL
IPC: E21B36/00
Filed: 2001-04-24
Abstract: A method for treating a hydrocarbon containing formation in situ and producing a hydrocarbon fluid from the formation is disclosed. The method comprises pyrolysing hydrocarbons present in the formation during the production of the hydrocarbon fluid from the formation with the application of a pressure/temperature control. The method is characterised in that the pressure is at least the pressure which can be calculated for a selected temperature, or the temperature is at most the temperature which can be calculated for a selected pressure from the equation: P = 0.07 *__-A__ + B   ET + 273  P is pressure (bar absolute), T is temperature (oC), A and B are predetermined parameters. Where A is at least 5000, B is at least 10 and P is at most 72 bar absolute. The above described temperature controls a property which is relevant to the quantity, the composition and or the quality of the hydrocarbon fluids produced.
Patent NZ-522940-A (NZ)
Title: Crystal modification
Inventor: DAVIES JULIAN ANTHONY
IPC: C07D211/22
Filed: 2001-06-06
Abstract: A crystal modification of alpha,alpha-dimethyl-4-{1-hydroxy-4-{4-(hydroxydiphenylmethyl)-1-piperidinyl}butyl}benzeneacetic acid hydrochloride , characterized by powder x-ray diffraction peaks at d spacings of about 10.5, 8.1, 5.5, 5.4, 5.2, 4,.42, 4.15, 3.82, 3.35. Such crystal modifications have a melting point in the range of 138-148 degrees C.
Patent NZ-523724-A (NZ)
Title: Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
Inventor: ASSENS JEAN-LOUIS
IPC: C07D405/04
Filed: 2001-08-23
Abstract: Disclosed are benzofuran or benzothiophene derivative compounds of formula (1), wherein: A is -O- or -S-, X is -O- or -S-, B is an alkylene optionally substituted with hydroxy, T is H or alkyl, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of cardiovascular diseases.
Patent NZ-525023-A (NZ)
Title: A bovine genotyping test
Inventor: SNELL RUSSELL GRANT
IPC: G01N33/00
Filed: 2003-03-28
Abstract: A method of assessing the genetic merit of a bovine with respect to Epidermolysis bullosa (EB) simplex which comprises the step of determining the keratin 5 genotypic state of the bovine. Also covered are primers for amplifying the keratin 5 gene, a kit for detecting the genotypic status of a bovine and a method for selecting a bovine with a specific genotypic state. Semen produced by a bull selected by the above method is also included.
Patent NZ-525287-A (NZ)
Title: Particulate and process gas stream sampler
Inventor: DAHLIN ROBERT S
IPC: B04C5/185
Filed: 2001-09-25
Abstract: A sampling system (10) samples particulate material in a high-temperature, high-pressure gas stream (20) flowing in process pipe (22). A sampling device (12) comprising an alumina lined activated bauxite alkali vapor collector (16) and a threadless sacrificial connector containing cyclone separator (14) is inserted into stream (20) via a pipe flange (24) connected to block-and-bleed valves (52, 54). (In alternative embodiments instead of a cyclone separator (14) a cascade impactor (240) with integrally spaced and aligned jet plates (282) having collection substrates (284) may be used). Support structure (30) supports a stepper motor (32) driving screw actuator (34) carrying draw yode (38) is driven along linear bearing rail (40) by engagement with screw actuator (34). Draw yoke (38) engages sampling device carrying probe (42) so as to move in axial direction (A). Probe rotator (44) mounted to carriage (39) can be controlled or monitored by local controller/monitor (46) or remote one (48) which can also monitor and control axial movement production.
Patent NZ-526923-A (NZ)
Title: Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
Inventor: ALLEGRETTI MARCELLO
IPC: A61P17/02
Filed: 2002-02-25
Abstract: (R) -2-Arylpropionamide compounds of formula (I) are described, wherein the variables are as defined in the specification. The process for their preparation and pharmaceutical preparations thereof are also described. These 2-Arylpropionamides are useful in the prevention and treatment of tissue damage due to the exacerbate recruitment of polymorphonuclear leukocytes (Leukocytes PMN) and of monocytes at the inflammatory sites. Particularly disclosed are the R enantiomers of omega-aminoalkylamides of 2-aryl propionic acids, of formula (I), for use in the inhibition of the chemataxis of neutrophils and monocites induced by the C5a fraction of the complement and by other chemotactic proteins whose biological activity is associated with activation of a 7-TD receptor. Selected compounds of formula (I) are dual inhibitors of both the C5a-induced chemotaxis of nutrophils and monocytes and the IL-8-induced chemotaxis of PMN leukocytes. These compounds are suitable for use in the treatment of psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, rheumatoid arthritis and in the prevention and the treatment of injury caused by ischemia and reperfusion.
Patent NZ-532783-A (NZ)
Title: A surfboard lock
Inventor: MILLIST MICHAEL
IPC: B63B35/79
Filed: 2002-10-23
Abstract: A surfboard lock is described being of unitary construction and including a lock body including two engagement members; the engagement members are movable from a retracted position to an extended position and may be locked in the extended position; in the retracted position the engagement members may be at least partially introduced into the fin box opening of a surfboard; in the extended position the engagement members may engage with the internal walls of the fin box opening to resist removal of the lock there from; and attachment means affixed to the lock body for attaching the lock to a sturdy object.
Patent NZ-545502-A (NZ)
Title: Alpha-aminoamide derivatives useful as anti-inflammatory agents
Inventor: SALVATI PATRICIA
IPC: A61K31/165
Filed: 2004-04-22
Abstract: Disclosed is the use of an alpha-aminoamide compound of formula (I) wherein the substituents are disclosed within the specification or mixtures, and pharmaceutically acceptable salts or esters thereof, as an anti-inflammatory agent, for the preparation of a medicament for the treatment of inflammatory disorders.
Patent NZ-547092-A (NZ)
Title: Apparatus and method for reducing and removing airborne oxidized particulates
Inventor: BORISENKO ALEXANDER VASILIEVICH
IPC: C01B31/02
Filed: 2004-11-12
Abstract: An apparatus (10) and method for recovering elemental carbon, elemental sulphur, elemental iron, elemental gold and other elemental materials from an air flow including a funnel-shaped receptor (14) and an inverted cone-shape electrode node body (12) spaced from the funnel receptor, a funnel-shaped reaction zone (45) between the outer surface of the electrode node body and the inner surface (60) of the receptor for receiving the air flow, and a plurality of point source electrodes (36) mounted to the electrode node body (12) and projecting into the reaction zone (45). The electrode node body (12) and the receptor (14) are electrically isolated from each other, the receptor (14) is connected to ground, and a voltage source is electrically connected to the electrode node body (12). The apparatus and method may be used for treating an air flow containing pollutants generated from the burning of fossil fuels, trash and other materials to reduce the oxides to elemental matter and water and to remove the elemental matter from the air flow, for treating emissions of coal-operated power plants to improve their efficiency by recovering carbon from the plant emissions and reusing the recovered carbon as fuel, to reduce landfill requirements by burning trash in incinerators and treating the incinerator emissions to recover elemental material which is then land-filled in far less space than the original unburned trash, and to produce valuable elemental material such as fullerenes.
Patent NZ-547806-A (NZ)
Title: Process for producing pellets for pharmaceutical compositions
Inventor: SPIERS CHRISTOPHER
IPC: A61K31/00
Filed: 2004-12-15
Abstract: A process for the production of particles for use in a pharmaceutical composition is disclosed, wherein the process comprises: mixing water with a component composition comprising at least a rheology modifying agent and a therapeutically active compound to produce a paste; extruding at least a portion of the paste to form extrudate; spheronising at least a portion of the extrudate to form spheronised particles; and drying at least a portion of the spheronised particles, wherein the process comprises controlling the amount of water used with the component composition so as to obtain a particle size distribution such that from about 80% to about 98% of the particles have a diameter from about 800 to about 1500 micrometers.
Patent NZ-547949-A (NZ)
Title: Resilient protector to protect a structure from an impact
Inventor: HUXTABLE PAUL STEWART
IPC: F16F7/00
Filed: 2004-11-18
Abstract: A protecting apparatus (10) for protecting a structure (100) from an impact. The protecting apparatus is arranged to be mounted on the structure and includes a bumper member (12), a structure positioning member (14) and at least one resiliently flexible joining portion (16). The structure positioning member is arranged in use to be positioned in contact with or adjacent to a portion of the structure being protected. The at least one resiliently flexible joining portion extends between the bumper member and the structure positioning member so that when an outer surface (12a) of the bumper member is impacted, the impact force is dissipated at least in part by flexure of the at least one joining portion.
Patent NZ-549069-A (NZ)
Title: Diaminopyrimidines as P2X3 and P2X2/3 antagonists
Inventor: CARTER DAVID SCOTT
IPC: A61K31/506
Filed: 2005-02-25
Abstract: Disclosed is a diaminopyrimidine compound of formula (I) wherein X is -O-; R1 is isopropyl; R3 is methoxy and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula (I) in the manufacture of a medicament for the treatment of a disease mediated by a P2X3 or P2X2/3 receptor antagonist such as genitourinary disease or a disease associated with pain.